openPR Logo
Press release

Thyroid Test Market to Reach USD 3.94 Billion by 2034

11-11-2025 11:09 AM CET | Health & Medicine

Press release from: Exactitude Consultancy

Thyroid Test

Thyroid Test

The Global Thyroid Test Market is witnessing strong momentum as healthcare providers prioritize early detection of thyroid dysfunction through advanced diagnostics and automated testing solutions. According to Exactitude Consultancy, the market, valued at USD 2.45 billion in 2024, is projected to reach USD 3.94 billion by 2034, growing at a CAGR of 4.8 % during 2025-2034.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/49866

Increased prevalence of hypothyroidism, hyperthyroidism, and autoimmune thyroid diseases, along with expanding screening programs and technological innovation in immunoassay platforms, are the key factors driving market expansion worldwide.

Key Takeaways
• Market Size: USD 2.45 billion (2024) → USD 3.94 billion (2034)
• CAGR: 4.8 % (2025-2034)
• Dominant Test Type: Thyroid-stimulating hormone (TSH) tests lead global market demand
• Emerging Trend: Point-of-care and home-based thyroid testing devices
• Top Regions: North America leads; Asia-Pacific to register the highest growth rate

Market Story
Thyroid disorders are among the most prevalent endocrine diseases globally, affecting metabolism, cardiovascular health, and reproductive systems.
The growing incidence of lifestyle-related conditions, rising geriatric population, and improved access to diagnostic facilities have increased the adoption of thyroid function tests (TFTs) worldwide.

Laboratories and diagnostic centers are rapidly deploying automated immunoassay analyzers, chemiluminescence platforms, and ELISA systems to enhance testing accuracy and turnaround time.

In parallel, point-of-care (POC) devices and home self-test kits are gaining traction due to the convenience and need for continuous health monitoring.
Government initiatives promoting early screening and awareness campaigns, particularly in emerging economies, are contributing to the widespread availability of thyroid testing services.

Segmentation Overview
By Test Type
• TSH (Thyroid Stimulating Hormone) Test
• T3 (Triiodothyronine) Test
• T4 (Thyroxine) Test
• Thyroid Antibody Tests (Anti-Tg, Anti-TPO)
• Others

By Technique
• ELISA (Enzyme-Linked Immunosorbent Assay)
• Chemiluminescence Immunoassay (CLIA)
• Radioimmunoassay (RIA)
• Others

By End User
• Hospitals
• Diagnostic Laboratories
• Research & Academic Institutes
• Homecare Settings

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Explore Full Report here: https://exactitudeconsultancy.com/reports/49866/thyroid-test-market

Recent Developments
• Abbott Laboratories expanded its ARCHITECT i System range with enhanced thyroid hormone assay sensitivity.
• Siemens Healthineers launched Atellica® IM Thyroid Panel for faster, multi-analyte testing with automated sample handling.
• Danaher Corporation (Beckman Coulter) introduced upgraded CLIA platforms for thyroid profile accuracy and efficiency.
• Thermo Fisher Scientific Inc. enhanced its ELISA-based thyroid hormone kits for clinical and research applications.
• Mindray Medical International introduced affordable immunoassay analyzers to strengthen diagnostic access in emerging economies.

Expert Quote
"As diagnostic precision and automation converge, thyroid testing is becoming faster, smarter, and more accessible.
The integration of digital health tools and portable devices is shaping the future of endocrine diagnostics,"
said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.

Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49866

Market Drivers
• Increasing global prevalence of thyroid disorders and metabolic diseases
• Growing adoption of automated immunoassay systems
• Expansion of point-of-care and at-home diagnostic solutions
• Government initiatives for public health screening programs
• Rising awareness of preventive healthcare and endocrine health management

Forecast and Outlook
Between 2025 and 2034, the thyroid test market will evolve toward digitally connected diagnostic ecosystems, enabling faster and decentralized testing.
Advances in AI-powered assay interpretation, wearable biosensors, and remote testing platforms will enhance accessibility and accuracy.

As consumer awareness and personalized health monitoring rise, the adoption of smart home-based testing kits will expand rapidly, especially in Asia-Pacific and Latin America.
Simultaneously, collaborations between diagnostic manufacturers, hospitals, and telemedicine platforms will enhance integrated care delivery.

Regional Insights
• North America: Largest market; dominated by high diagnostic volumes and advanced laboratory infrastructure.
• Europe: Growth driven by strong reimbursement policies and increasing awareness of thyroid disorders.
• Asia-Pacific: Fastest-growing region; rapid healthcare digitalization and screening programs in India, China, and Japan.
• Latin America: Rising diagnostic investments and expanding telehealth services.
• Middle East & Africa: Steady adoption through government-led healthcare modernization projects.

Conclusion
The Global Thyroid Test Market is entering a new phase of automation, miniaturization, and accessibility.

As early detection and continuous monitoring gain importance, the integration of smart diagnostics, AI analytics, and home-based testing will redefine endocrine healthcare delivery.

Manufacturers prioritizing affordable, connected, and high-accuracy testing solutions are positioned to lead in this evolving global market.

This report is also available in the following languages : Japanese (甲状腺検査市場), Korean (갑상선 검사 시장), Chinese (甲状腺检测市场), French (Marché des tests thyroïdiens), German (Markt für Schilddrüsentests), and Italian (Mercato dei test sulla tiroide), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/49866

Related Reports
Secondary Hyperparathyroidism Market
https://exactitudeconsultancy.com/reports/72046/secondary-hyperparathyroidism-market

Thyroid Eye Disease Market
https://exactitudeconsultancy.com/reports/72240/thyroid-eye-disease-market

Exophthalmos Market
https://exactitudeconsultancy.com/reports/72255/exophthalmos-market

Cabozantinib (Cometriq) Market
https://exactitudeconsultancy.com/reports/75256/cabozantinib-cometriq-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Thyroid Test Market to Reach USD 3.94 Billion by 2034 here

News-ID: 4263909 • Views:

More Releases from Exactitude Consultancy

Glycine Supplement Market to Reach USD 1.72 Billion by 2034
Glycine Supplement Market to Reach USD 1.72 Billion by 2034
The Global Glycine Supplement Market is experiencing robust growth as consumers increasingly prioritize nutritional balance, muscle recovery, and mental well-being. According to Exactitude Consultancy, the market, valued at USD 1.02 billion in 2024, is projected to reach USD 1.72 billion by 2034, growing at a CAGR of 5.3 % during 2025-2034. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/49868 Glycine - a non-essential amino acid - is gaining attention for
Food Allergy Diagnosis & Treatment Market to Surpass USD 11.2 Billion by 2034
Food Allergy Diagnosis & Treatment Market to Surpass USD 11.2 Billion by 2034
Pune, India, November 11, 2025 - The global Food Allergy Diagnosis & Treatment Market is projected to grow from USD 6.1 billion in 2024 to USD 11.2 billion by 2034, registering a CAGR of 6.2 %, according to Exactitude Consultancy. The surge in food allergy prevalence, particularly among children, coupled with advances in molecular diagnostics, immunotherapy, and AI-driven allergy profiling, is fueling robust market expansion worldwide. Download Full PDF Sample Copy
Systemic Lupus Erythematosus (SLE) Treatment Market to Reach USD 5.18 Billion by 2034
Systemic Lupus Erythematosus (SLE) Treatment Market to Reach USD 5.18 Billion by …
The Global Systemic Lupus Erythematosus (SLE) Treatment Market is undergoing rapid transformation as pharmaceutical innovation, biologic therapies, and improved diagnostic techniques redefine disease management. According to Exactitude Consultancy, the market, valued at USD 3.16 billion in 2024, is projected to reach USD 5.18 billion by 2034, growing at a CAGR of 5.1 % between 2025 and 2034. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/49864 SLE - a chronic autoimmune
Generic Injectables Market to Surpass USD 195.6 Billion by 2034
Generic Injectables Market to Surpass USD 195.6 Billion by 2034
Pune, India, November 11, 2025 - The global Generic Injectables Market is projected to grow from USD 106.4 billion in 2024 to USD 195.6 billion by 2034, expanding at a CAGR of 6.2 %, according to Exactitude Consultancy. The market's momentum is driven by patent expiries of blockbuster biologics, increasing drug shortages, and the growing prevalence of chronic diseases requiring injectable therapies. Download Full PDF Sample Copy of Market Report @

All 5 Releases


More Releases for Thyroid

Rising Incidences of Thyroid Disorders Fuel Growth In The Thyroid Function Test …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Thyroid Function Test Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for thyroid function tests has witnessed substantial growth in the past few years. The market is projected to expand from $1.7 billion in 2024 to $1.81 billion in 2025, with an
Rising Incidences of Thyroid Disorders Fuel Growth In The Thyroid Function Test …
The Thyroid Function Test Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Thyroid Function Test Market Size During the Forecast Period? The thyroid function test market has grown significantly in recent years. It is expected to grow from $1.7 billion in 2024
Thyroid Function Test Market Report 2024 - Thyroid Function Test Market Growth A …
"The Business Research Company recently released a comprehensive report on the Global Thyroid Function Test Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive
Thyroid Ablation Devices Market
Alarming rise in prevalence of thyroid cancer, advancements in thyroid ablation system, rise in government & private funds for development of healthcare sectors, and increase in number of thyroid nodule cases are expected to notably contribute toward the growth of the global thyroid ablation devices market during the forecast period. Rise in prevalence of thyroid cancer and thyroid nodules, demand for minimally invasive procedures, and technological advancements in ablation devices drive
Thyroid Gland Disorders Treatment Market Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
Thyroid gland is made of thyroid cells that absorb iodine from food and convert it into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism. Thyroid gland disorders are defined as an abnormal release of thyroid hormones which may demand proper therapeutic agents to correct the disorder condition. This report studies the market in a view